The Beauty Health Company (NASDAQ:SKIN) Stock Has Average Price Target of $18.00

Key Points

• Analysts have a consensus “Hold” rating on Beauty Health, with six holds, one sell and one buy. The average 12-month price target is $18.00.
• Institutional investors own 93.26% of the company, with Bank of America and Renaissance Technologies increasing their positions and Capricorn Fund Managers initiating a roughly $17.3 million stake.
• Shares opened at $10.12, near the 52-week low of $9.89 and well below the $34.80 high. The company recently reported a quarterly loss of $0.40 per share, better than estimates, but revenue of $72.11 million fell short of expectations.

The Beauty Health Company (NASDAQ:SKIN - Get Free Report) has received an average rating of "Hold" from the eight ratings firms that are covering the company, Marketbeat.com reports. One analyst has rated the stock with a sell rating, six have assigned a hold rating and one has issued a buy rating on the company. The average 1 year price objective among analysts that have issued ratings on the stock in the last year is $18.00.

A number of equities analysts recently weighed in on the company. Weiss Ratings reissued a "sell (e+)" rating on shares of Beauty Health in a report on Wednesday, October 21st. Zacks Research downgraded Beauty Health from a "strong-buy" rating to a "hold" rating in a research report on Monday, July 20th. Jefferies Financial Group reaffirmed a "hold" rating and issued a $11.00 target price (up from $0.85) on shares of Beauty Health in a research note on Monday, October 19th. Stifel Nicolaus set a $10.00 price target on shares of Beauty Health in a research report on Thursday, October 15th. Finally, Citigroup reiterated a "hold" rating on shares of Beauty Health in a research report on Thursday, October 15th.

Hedge Funds Weigh In On Beauty Health

Several institutional investors and hedge funds have recently made changes to their positions in SKIN. Bank of America Corp DE raised its position in Beauty Health by 19.2% in the 1st quarter. Bank of America Corp DE now owns 106,242 shares of the company's stock worth $95,000 after purchasing an additional 17,088 shares during the period. Renaissance Technologies LLC boosted its position in Beauty Health by 29.6% during the first quarter. Renaissance Technologies LLC now owns 283,791 shares of the company's stock valued at $253,000 after buying an additional 64,900 shares during the period. Finally, Capricorn Fund Managers Ltd purchased a new stake in Beauty Health during the first quarter valued at about $17,270,000. Institutional investors own 93.26% of the company's stock.

Beauty Health Stock Performance

Shares of NASDAQ:SKIN opened at $10.12 on Wednesday. Beauty Health has a 52-week low of $9.89 and a 52-week high of $34.80. The firm has a fifty day moving average of $12.60 and a 200 day moving average of $17.15. The firm has a market capitalization of $65.85 million, a PE ratio of -2.30 and a beta of 1.05.

Beauty Health (NASDAQ:SKIN - Get Free Report) last released its earnings results on Thursday, August 6th. The company reported ($0.40) EPS for the quarter, beating analysts' consensus estimates of ($0.50) by $0.10. The firm had revenue of $72.11 million during the quarter, compared to the consensus estimate of $74.45 million. On average, sell-side analysts forecast that Beauty Health will post -3.18 EPS for the current fiscal year.

Beauty Health Company Profile

BeautyHealth is a global health and beauty company focused on providing technology, products and services for aesthetic and skincare businesses. Its flagship brand, HydraFacial, offers a non-invasive treatment platform that combines cleansing, exfoliation, extraction and hydration, with treatments delivered through proprietary devices and consumable solutions.

The company also provides professional skincare products, treatment systems and related solutions designed for use by physicians, dermatologists, aestheticians and other licensed practitioners.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.